Research Publications

Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight.

Karl D, Philis-Tsimikas A, Darsow T, Lorenzi G, Kellmeyer T, Lutz K, Wang Y, Frias JP

Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program.

Philis-Tsimikas A, Zhang Q, Walker C

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.

Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B

The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management.

Roges OA, Baron M, Philis-Tsimikas A

Outcomes of Project Dulce: a culturally specific diabetes management program.

Gilmer TP, Philis-Tsimikas A, Walker C

Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study.

Benoit SR, Fleming R, Philis-Tsimikas A, Ji M

Predictors of dropouts from a San Diego diabetes program: a case control study.

Benoit SR, Ji M, Fleming R, Philis-Tsimikas A

Improvement in diabetes care of underinsured patients enrolled in project dulce: a community-based, culturally appropriate, nurse case management and peer education diabetes care model.

Philis-Tsimikas A, Walker C, Rivard L, Talavera G, Reimann JO, Salmon M, Araujo R, Project Dulce

Improved care for diabetes in underserved populations.

Philis-Tsimikas A, Walker C

LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed to oxidative stress.

Tsimikas S, Philis-Tsimikas A, Alexopoulos S, Sigari F, Lee C, Reaven PD